Back to SNDX

Prosight Management, LP → SNDX

Prosight Management, LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$15.3M
Q3 2026
Peak value
$26.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$14M
Q1 2026$18M
Q2 2026$26.2M
Q3 2026$15.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.3M812.6K——
Q2 2026$26.2M1.20M——
Q1 2026$18M770.0K——
Q4 2025$14M665.0K——

Other funds holding SNDX

Other Prosight Management, LP positions

GLPGF

LAKEFRONT BIOTHERAPEUTICS NV

$61.3M
GLPGF

LAKEFRONT BIOTHERAPEUTICS NV

$59.3M
JANX

JANUX THERAPEUTICS INC

$58.4M
NKTR

NEKTAR THERAPEUTICS

$56.5M
BSX

BOSTON SCIENTIFIC CORP

$54.2M
NKTR

NEKTAR THERAPEUTICS

$52.9M
STTK

SHATTUCK LABS INC

$52.2M
JANX

JANUX THERAPEUTICS INC

$50.9M